Gene · 55811
ADCY10: adenylate cyclase 10
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ADCY10: adenylate cyclase 10. Genes, record 55811. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55811
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96PN6 | Adenylate cyclase type 10 | 1,610 | 37 | Ensembl, GeneID, HGNC |
Source UniProt
Patents12
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 8500 | Q96PN6 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 286 | Q96PN6 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 286 | Q96PN6 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8500 | Q96PN6 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 2786 | Q96PN6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 2786 | Q96PN6 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 4445 | Q96PN6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 105757 | Q96PN6 | Espacenet |
| US 10941186 B2 | 2021-03-09 | 39 | Q96PN6 | Espacenet |
| US 9952224 B2 | 2018-04-24 | 7 | Q96PN6 | Espacenet |
1 to 10 of 12
See all 12 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,810
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ADCY10 papers | Newest fiscal year |
|---|---|---|---|
| R01HD038082 | Sperm Ca2+ signaling and energy pathways in basic science and ART | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| R01HD088571 | Comparative studies on the regulation of metabolism during sperm capacitation | 6 | 2025 |
| R35CA197622 | Live-cell Activity Architecture in Cancer | 6 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 4 | 2025 |
| R01DK073368 | Mechanisms of Compartmentalized cAMP Signaling | 4 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 3 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,810Source NIH's project files
See all 1,810 nih grantsPapers2,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adenylyl Cyclase (ADCY) Protein Family: Molecular Mechanisms and Therapeutic Potential in Glucose and Lipid Metabolism and Feeding Regulation. | J Cell Physiol | 2026 | 42596553 | PubTator, text mining | PubMed |
| Differential expression patterns of selective energy metabolism associated genes in fresh and freeze-thawed bubaline spermatozoa at uniform durations of in vitro capacitation. | Cryobiology | 2026 | 42308645 | PubTator, text mining | PubMed |
| Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinism. | bioRxiv | 2026 | 42244781 | PubTator, text mining | PubMed |
| Assessing efficacy of ADCY10 inhibitors in cervical mucus. | Mol Hum Reprod | 2026 | 42241232 | PubTator, text mining | PubMed |
| Coronavirus nucleocapsid proteins hijack host protein kinase A catalytic subunit α into nucleus to evade from STAT1 signaling. | Int J Biol Macromol | 2026 | 42034941 | PubTator, text mining | PubMed |
| Targeting Soluble Adenylyl Cyclase for On-Demand Contraception. | Physiology (Bethesda) | 2026 | 41843491 | PubTator, text mining | PubMed |
| A Rare Case of Asymptomatic Insulinoma with Mesocolonic Lymph Node Metastases and Long-Term Stability. | Surg Case Rep | 2026 | 41783329 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Biochemical characterization of the full-length isoform of soluble adenylyl cyclase. | J Biol Chem | 2025 | 41197733 | PubTator, text mining | PubMed |
| Integrative assessment of RNA sequencing and in silico analysis to pinpoint mRNAs, lncRNAs, and circRNAs interactions with miRNAs underlying arsenic-induced neurotoxicity. | BMC Genomics | 2025 | 40999364 | PubTator, text mining | PubMed |
1 to 10 of 2,419
See all 2,419 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55811
GET https://conductscience.org/api/genes/v1/55811/patents